olivLaw · European equity research
Εβροφαρμα Βιομηχανια Γαλακτος Ανωνυμη Βιομηχανικη & Εμπορικη Εταιρεια Α.ε. EVROF.AT
Greece · Athens Stock Exchange · ISIN GRS385113006 · Vertical: Listed companies from Greece
At the close of 05 Nov 2026, Εβροφαρμα Βιομηχανια Γαλακτος Ανωνυμη Βιομηχανικη & Εμπορικη Εταιρεια Α.ε. (EVROF.AT) stock was 3.70 EUR (−0.54% on the day), with market capitalisation 50.6 m EUR, P/E 14.3 on diluted EPS of 0.26 EUR over the last 12 months, dividend yield 1.34%, beta 0.67, 52-week range 2.65–4.31 EUR.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 46.1
- neutral
- Bollinger (20, 2)
- 3.58 – 3.84
- in the lower half of the band · %B 0.47 · band width 7.0%
- SMA 50 / 200
- 3.88 / 3.78
- mixed trend
- MACD (12, 26, 9)
- -0.05 / -0.06
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | −4.6% | +0.4% | −5.0 pp | — |
| 3 months | −2.1% | −3.3% | +1.1 pp | — |
| 6 months | −1.6% | +4.0% | −5.6 pp | — |
| Year to date | +2.5% | +8.1% | −5.6 pp | — |
| 1 year | +36.0% | +10.7% | +25.3 pp | +0.4% |
| 3 years | +283.4% | +50.1% | +233.3 pp | +34.3% |
| 5 years | +252.4% | +43.6% | +208.8 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 100 percentile of its own 3-quarter history (min 7.5, median 10.9, max 14.0; quarters with earnings only).
Fiscal years
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | unavailable | unavailable | unavailable |
| Revenue YoY | unavailable | unavailable | unavailable |
| Net income | 2.2 m | 2.3 m | 3.5 m |
| Net income YoY | unavailable | +3.5% | +54.6% |
| Diluted EPS | 0.16 | 0.17 | 0.26 |
| Diluted EPS YoY | unavailable | +3.5% | +54.7% |
| net % | unavailable | unavailable | unavailable |
| Free cash flow | 713.0 k | 4.1 m | -509.0 k |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 6.6 m EUR
- Financial debt
- 16.9 m EUR
- Net debt
- 10.4 m EUR
- Equity
- 20.7 m EUR
- Total assets
- 56.3 m EUR
- Debt / equity
- 0.82x
- Current ratio
- 2.23x
- ROE
- 18.3%
- ROA
- 6.7%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (EUR)
Income statement · EUR
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Gross profit | 8.6 m | 10.2 m | 12.1 m | esef· 23 Oct 2026verified |
| Research & development | 7.9 m | 7.6 m | 7.7 m | esef· 23 Oct 2026verified |
| Operating income | 4.0 m | 4.1 m | 5.2 m | esef· 23 Oct 2026verified |
| Interest expense | 1.4 m | 1.2 m | 697.0 k | esef· 23 Oct 2026verified |
| Pre-tax income | 2.7 m | 2.9 m | 4.5 m | esef· 23 Oct 2026verified |
| Income tax | 505.0 k | 608.0 k | 1.0 m | esef· 23 Oct 2026verified |
| Net income | 2.2 m | 2.3 m | 3.5 m | esef· 23 Oct 2026verified |
| Diluted EPS | 0.16 | 0.17 | 0.26 | esef· 23 Oct 2026verified |
| Dividend per share | 0.00 | 0.05 | 0.05 | esef· 23 Oct 2026derived |
Balance sheet · EUR
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Cash | 657.0 k | 3.3 m | 6.6 m | esef· 23 Oct 2026verified |
| Receivables | 9.2 m | 7.4 m | 10.2 m | esef· 23 Oct 2026verified |
| Inventories | 6.2 m | 7.0 m | 7.0 m | esef· 23 Oct 2026verified |
| Current assets | 16.3 m | 17.8 m | 23.8 m | esef· 23 Oct 2026verified |
| Property, plant & equipment, net | 25.5 m | 24.7 m | 25.9 m | esef· 23 Oct 2026verified |
| Intangibles (excl. goodwill) | 45.0 k | 131.0 k | 345.0 k | esef· 23 Oct 2026verified |
| Total assets | 47.4 m | 48.2 m | 56.3 m | esef· 23 Oct 2026verified |
| Accounts payable | 5.6 m | 6.1 m | 7.9 m | esef· 23 Oct 2026verified |
| Short-term debt | 7.0 m | 11.6 m | 2.0 m | esef· 23 Oct 2026verified |
| Long-term debt | 12.4 m | 5.2 m | 14.9 m | esef· 23 Oct 2026verified |
| Current liabilities | 13.0 m | 18.3 m | 10.7 m | esef· 23 Oct 2026verified |
| Total liabilities | 31.1 m | 30.4 m | 35.7 m | esef· 23 Oct 2026verified |
| Equity | 16.2 m | 17.8 m | 20.7 m | esef· 23 Oct 2026verified |
| Shares outstanding at year end | 13.7 m | 13.7 m | 13.7 m | esef· 23 Oct 2026derived |
Cash flow · EUR
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | 3.1 m | 5.4 m | 3.6 m | esef· 23 Oct 2026verified |
| Capex | 2.4 m | 1.2 m | 4.1 m | esef· 23 Oct 2026verified |
| Free cash flow | 713.0 k ≈ | 4.1 m ≈ | -509.0 k ≈ | esef· 23 Oct 2026derived |
| Investing cash flow | -2.0 m | 738.0 k | 230.0 k | esef· 23 Oct 2026verified |
| Financing cash flow | -1.9 m | -3.4 m | -580.0 k | esef· 23 Oct 2026verified |
| Dividends paid | 0 | 680.0 k | 680.0 k | esef· 23 Oct 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 52.1% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 50.6 m EUR
Key indicators
Coverage and freshness
Score by group
52% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 2.14 – 3.49 EUR.
Methods computed but outside the aggregate range: Dividend discount (DDM) (a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate).
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (EUR per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E2.14 – 3.49 (Mid 2.85)27 companies used · median multiple 11.0x · quartiles 8.3x – 13.5xAEGN.AT, AEM.AT, ALMY.AT, ASCO.AT, ASTAK.AT, AVAX.AT, BELA.AT, BIOKA.AT, BIOSK.AT, BIOT.AT, BRIQ.AT, BYLOT.AT, CENER.AT, CENTR.AT, DAIOS.AT, DIMAND.AT, EIS.AT, ELBE.AT, ELHA.AT, ELLAKTOR.AT, ELSTR.AT, ELTON.AT, ETE.AT, EUROB.AT, EYAPS.AT, FAIS.AT, FLEXO.AT
- Dividend discount (DDM)outside the aggregate0.68 – 0.92 (Mid 0.78)a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate
Assumptions (illustrative, editorial)
- Risk-free rate
- 3.0%
- Equity risk premium
- 5.5%
- Beta (default)
- 1.00
- Cost of equity
- 8.5%
- Terminal growth
- 2.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 52.1% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 13.1% | 75 (vs peers) | 20% |
| Net margin · Quality | unavailable | unavailable | — |
| FCF conversion · Quality | -14.4% | 0 (on a fixed band) | 12% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 7.5x | 92 (on a fixed band) | 12% |
| Current ratio · Balance sheet | 2.2x | 100 (on a fixed band) | 8% |
| P/E (TTM) · Valuation | 14.3x | 32 (vs peers) | 20% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -1.0% | 0 (on a fixed band) | 16% |
| Shareholder yield (distributions) · Returns | 1.3% | 19 (on a fixed band) | 12% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet95/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality47/100 · 2/3 factors with a value
- Returns· partial19/100 · 1/2 factors with a value
- Valuation18/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
ΕΒΡΟΦΑΡΜΑ ΒΙΟΜΗΧΑΝΙΑ ΓΑΛΑΚΤΟΣ ΑΝΩΝΥΜΗ ΒΙΟΜΗΧΑΝΙΚΗ & ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ Α.Ε. (EVROF.AT). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: ROE 18.3%.
The estimated value range is 2.14–3.49 EUR per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 2.85 EUR, the price of 3.70 EUR leaves a potential of -23.1% (value / price − 1) and a margin of safety of -30.0% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 52.1% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 13.1%
- Interest coverage: 7.5x
- Current ratio: 2.2x
What contradicts it
- FCF conversion: -14.4%
- FCF yield: -1.0%
- Shareholder yield (distributions): 1.3%
- The price is above the estimated value range
Not assessed (insufficient data or a ratio without meaning): Net margin, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Listed companies from Greece · same country · compared with 40 companies
Multiples and returns vs the median
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| EUROB.ATΤραπεζα Eurobank Ανωνυμη Eταιρεια | 17.3 bn | 12.7 | 14.0% | 39.7% | +2.7% | +38% / +178% |
| ETE.ATΕθνικη Τραπεζα Της Ελλαδος Α.ε. | 15.2 bn | 13.1 | 13.3% | 42.5% | −5.4% | +24% / +167% |
| ELPE.ATHelleniq Energy Ανωνυμη Εταιρεια Συμμετοχων | 4.9 bn | 28.5 | 6.4% | 1.5% | −9.0% | +97% / +114% |
| CENER.ATCenergy Holdings | 4.5 bn | 23.5 | 24.3% | 9.4% | +14.7% | +45% / +207% |
| BELA.ATJumbo Ανωνυμη Εμπορικη Εταιρεια | 3.7 bn | 11.6 | 21.5% | 26.0% | +7.2% | +1% / +15% |
| AKTR.ATΑκtor Ανώνυμη Εταιρεία Συμμετοχών, Τεχνικών Και Ενεργειακών Έργων | 2.0 bn | 110.5 | 6.7% | 1.3% | +11.2% | +7% / +186% |
| EYDAP.ATΕταιρια Υδρευσεως Και Αποχετευσεως Πρωτευουσης Ανωνυμη Εταιρια | 1.5 bn | — | -2.6% | -5.9% | −2.4% | +86% / +136% |
| ELHA.ATEλβαλχαλκορ Ελληνικη Βιομηχανια Χαλκου Και Αλουμινιου Ανωνυμος Εταιρεια | 1.3 bn | 12.4 | 9.8% | 2.9% | +5.1% | +6% / +83% |
| AEGN.ATΑεροπορια Αιγαιου Ανωνυμη Αεροπορικη Εταιρεια | 1.0 bn | 6.9 | 27.7% | 7.9% | +4.6% | −21% / −1% |
| AVAX.ATΑβαξ Ανωνυμη Εταιρεια Εργοληπτικη-Τουριστικη-Εμπορικη-Βιομηχανικη-Οικοδομικων Υλικων & Μηχανηματων | 505.7 m | 10.7 | 25.9% | 5.0% | +47.1% | +40% / +123% |
| BYLOT.ATBally's Intralot Α.ε. | 464.8 m | 15.3 | -9.3% | -12.6% | +34.8% | +12% / +18% |
| ELLAKTOR.ATΕλλακτωρ Ανωνυμη Εταιρεια | 421.5 m | 2.7 | 26.1% | 175.2% | −74.8% | −32% / −44% |
| AEM.ATAlter Ego Media Α.ε. | 356.1 m | 18.1 | 18.3% | 14.0% | +12.6% | −2% / unavailable |
| ALMY.ATΑλουμυλ Βιομηχανια Αλουμινιου Αε | 324.0 m | 10.5 | 23.5% | 6.0% | +11.7% | +16% / +121% |
| DIMAND.ATDimand Ανωνυμη Εταιρεια Αξιοποιησης Και Εκμεταλλευσης Ακινητων Και Κατασκευων Υπηρεσιων Και Συμμετοχων | 266.7 m | 7.6 | 18.5% | 58.5% | +110.6% | +42% / +28% |
| EYAPS.ATΕταιρεια Υδρευσης & Αποχετευσης Θεσσαλονικης Α.ε. | 169.9 m | 22.0 | 4.1% | 8.8% | +2.4% | +24% / +42% |
| EVR.ATΕυρώπη Holdings Α.ε. | 168.6 m | 37.2 | 2.9% | 30.7% | +435.3% | −32% / +33% |
| BRIQ.ATBriq Properties Ανωνυμη Εταιρεια Επενδυσεων Σε Ακινητη Περιουσια | 150.0 m | 5.9 | 15.5% | 116.9% | +37.8% | +13% / +70% |
| FAIS.ATΦαις Συμμετοχων Ανωνυμη Εταιρεια | 117.2 m | 8.7 | 22.1% | 6.3% | +12.9% | −6% / unavailable |
| DAIOS.ATΔαϊος Πλαστικα Ανωνυμη Βιομηχανικη Εμπορικη Εταιρεια Α.ε. | 107.2 m | 10.9 | 14.0% | 15.6% | +9.1% | 0% / +123% |
| ASTAK.ATAlpha Real Estate Services Ae | 93.3 m | 12.4 | 10.4% | 30.3% | +22.4% | −8% / −8% |
| FLEXO.ATFlexopack Ανωνυμη Εμπορικη Και Βιομηχανικη Εταιρεια Πλαστικων | 92.5 m | 8.3 | 8.3% | 6.8% | +4.6% | −2% / −2% |
| ASCO.ATA.s. Εμπορικη-Βιομηχανικη Εταιρια Η/υ & Παιχνιδιων Α.ε. | 59.8 m | 10.5 | 14.1% | 15.8% | +16.4% | +11% / +106% |
| AVE.ATAve Α.ε. | 50.9 m | — | -25.2% | -7.4% | +8.2% | −7% / −12% |
| ELTON.ATΕλτον Διεθνους Εμποριου Ανωνυμη Εμπορικη Βιομηχανικη Εταιρεια | 47.3 m | 13.9 | 4.9% | 1.9% | +8.6% | −11% / −18% |
1- and 3-year price returns: for EVROF.AT from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202523 Oct 2026
- Annual report 202423 Oct 2026
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.